LAS VEGAS, May 12, 2014 /PRNewswire/ -- GrowBLOX Sciences,
Inc. (OTCQB: GBLX), announced today that it will exhibit the
Company at the upcoming MoneyShow in Las
Vegas, which will be held from May
12-15th at Caesar's Palace Hotel. Chief Executive Officer,
Craig Ellins, will present details
about the Company as well as industry insights regarding the
advancement of the medical cannabis industry. Mr. Ellins will be
speaking on Wednesday, May 14th at
2:15 p.m.
Investors are welcome to visit the GrowBLOX Sciences booth,
#702, in the Exhibit Hall. Admission is free and can be obtained at
www.moneyshow.com.
"We believe exhibiting at this premier conference is an
excellent opportunity to showcase the Company and to meet and
network with hundreds of qualified investors, equity traders, and
finance professionals," said Craig
Ellins, Chief Executive Officer of GrowBLOX Sciences. "We
are looking forward to sharing our latest developments in medical
cannabis cultivation technology and news on our Company's
direction."
For over 30 years, The MoneyShow has been a global, financial
media company known as a leading producer of investment tradeshows,
as well as producer of the award-winning, multimedia online
community, www.MoneyShow.com, and interactive eShows. The MoneyShow
gathers qualified investors, traders, and financial advisors,
representing billions in investment assets, providing them access
to the world's leading financial experts, business, and media
professionals. The MoneyShow has partnerships with leading
financial media companies; such as Forbes, Barron's, Morningstar,
CNBC, Investor's Business Daily, and Better Investing.
Top Wall Street investment and trading experts attract investors
to the MoneyShow who are eager to learn about investing in public
companies and to gain access to their professional advice and
buy-and-hold strategies.
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company
that has developed proprietary indoor growing chambers specifically
designed for medical cannabis cultivation. The GrowBLOX
chamber allows for completely controlled growing conditions,
ensuring the manufacture of a consistent, toxin-free, natural and
medicinal-grade product. The Company believes that the
advantages of a controlled environment over traditional outdoor or
greenhouse growing, will empower the public, nutraceutical and
pharmaceutical industries to embrace cannabis as an effective
treatment for a myriad of serious medical conditions.
http://www.gbsciences.com
Forward-Looking Statements
Except for historical information contained herein, the statements
in this release are forward-looking and made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements are inherently unreliable
and actual results may differ materially. Examples of
forward-looking statements in this news release include statements
regarding the payment of dividends, marketing and distribution
plans, development activities and anticipated operating
results. Factors which could cause actual results to differ
materially from these forward-looking statements include such
factors as the Company's ability to accomplish its business
initiatives, significant fluctuations in marketing expenses and
ability to achieve and expand significant levels of revenues, or
recognize net income, from the sale of its products and services,
as well as the introduction of competing products, or management's
ability to attract and maintain qualified personnel necessary for
the development and commercialization of its planned products, and
other information that may be detailed from time to time in the
Company's filings with the United States Securities and Exchange
Commission. The Company undertakes no obligation to publicly
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise.
Contact:
Craig Ellins
CEO, GrowBLOX Sciences, Inc.
+1-844-843-BLOX ext. 01
SOURCE GrowBLOX Sciences, Inc.